Key terms
About BNGO
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BNGO news
Apr 24
8:12am ET
Bionano Genomics announces publication on OGM’s structural variation detection
Apr 17
8:09am ET
Bionano Genomics enters partnership with Diagens
Apr 11
8:12am ET
Bionano Genomics announces publication showing OGM detects over 1250 variants
Apr 05
9:42am ET
BioNano Genomics Launches Offering to Bolster Finances
Apr 04
1:48pm ET
Bionano Genomics sells 8.7M shares at $1.145 in direct offering
Apr 03
8:26am ET
Bionano Genomics says OGM ‘exclusively detects alterations in known oncogenes’
Apr 02
8:17am ET
Bionano Genomics announces 9 poster presentations at AACR meeting
Mar 19
8:15am ET
Bionano Genomics announces publication of a breast cancer study with OGM
Mar 09
11:15am ET
BioNano Genomics (BNGO) Gets a Hold from Maxim Group
Mar 07
8:20am ET
Bionano Genomics announces lineup of content at ACMG
Mar 07
1:01am ET
A New Cause for Concern: Bionano Genomics Adds a New Share Price & Shareholder Rights Risk
Mar 05
4:10pm ET
Bionano Genomics sees Q1 revenue $8.25M-$8.75M, consensus $9.69M
Mar 05
4:08pm ET
Bionano Genomics sees FY24 revenue $37M $41M, consensus $47.17M
Mar 05
4:06pm ET
Bionano Genomics reports Q4 revenue $10.7M, consensus $10.58M
Mar 05
7:05am ET
Options Volatility and Implied Earnings Moves Today, March 05, 2024
Feb 28
8:32am ET
BioNano Genomics Enhances Capital Structure and Flexibility
Feb 28
8:08am ET
Bionano Genomics announces amendment to debt financing arrangement
Feb 22
8:09am ET
Bionano Genomics says ACMG includes OGM in technical laboratory standards
Feb 02
7:31am ET
Analysts Are Bullish on Top Healthcare Stocks: BioNano Genomics (BNGO), Legend Biotech (LEGN)
Jan 30
8:14am ET
Bionano Genomics announces conclusion of 2024 Symposium
Jan 25
1:35pm ET
Maxim Group Remains a Hold on BioNano Genomics (BNGO)
No recent press releases are available for BNGO
BNGO Financials
Key terms
Ad Feedback
BNGO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BNGO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range